Value of thromboelastography combined with anticoagulant detection in patients over 60 years of age with cardiovascular or cerebrovascular disease

Abstract

Background: Cardiovascular disease (CVD) and cerebrovascular disease (CBVD) are common diseases in middle-aged and elderly people with high morbidity, mortality and disability rates. Individualized assessment and treatment are helpful to improve the quality of life and prognosis of patients. Thrombelastography (TEG) is a method to evaluate the coagulation function of patient with whole blood. In this study, we investigated the correlation between TEG indicators and traditional indicators of coagulation, and evaluated the diagnostic value of TEG combined with indicators of coagulation in elderly patients with CVD and CBVD. Methods: We retrospectively analyzed the thrombelastographic indices and traditional indicators of coagulation in 285 cases of elderly patients with CBVD or CVD. All measures were performed by the

The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review

“…8 9 Even though TEG parameters are correlated with CCS in detecting hypo- or hypercoagulability, 10 11 TEG seems to be superior in predicting bleeding and the need for transfusions. 12 13 Currently, TEG is used in many acute clinical settings such as cardiopulmonary bypass, massive trauma, and liver transplant surgeries. 14 There is increasing interest in the use of TEG in the field of stroke due to its power in quantifying coagulability, fibrinolysis, and detecting the effects or harms of anticoagulant and antiplatelet therapy.…”